Distinguished in Small Cell Lung Cancer (SCLC)

Zhouguang G. Hui

Chinese Academy Of Medical Sciences And Peking Union Medical College, 
Beijing, CN 
Distinguished in Small Cell Lung Cancer (SCLC)
Chinese Academy Of Medical Sciences And Peking Union Medical College, 
Beijing, CN 
OverviewLocationsClinical Research

Overview

Zhouguang Hui practices in Beijing, China. Hui is rated as a Distinguished expert by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Their top areas of expertise are Esophageal Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Thymic Epithelial Tumor, and Thymectomy.

Their clinical research consists of co-authoring 138 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Small Cell Lung Cancer (SCLC).

Locations

Chinese Academy Of Medical Sciences And Peking Union Medical College, Beijing, 100000, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: January 28, 2025
Intervention Type: Device, Other
Study Phase: Phase 3

138 Total Publications

Beyond the SANO Trial: Reshaping Organ Preservation for Esophageal Cancer in the Era of Potent Neoadjuvant Therapies.
Beyond the SANO Trial: Reshaping Organ Preservation for Esophageal Cancer in the Era of Potent Neoadjuvant Therapies.
Journal: Thoracic cancer
Published: July 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hui's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile